Earlier this year, QIAGEN collaborated with Myriad Genetics to develop a globally distributable kit-based test for analyzing ... including sample preparation and PCR kits, QIAGEN expanded into ...

Qiagen (QGEN) shares up premarket after disclosing strong preliminary Q1 2025 results and raising full-year EPS outlook.

Venlo, the Netherlands, April 6, 2025 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announces preliminary Q1 2025 results that exceed the outlook for both net sales and adjusted earnings ...

Sales of the QuantiFERON latent TB test grew about 15% CER as global ... The QIAcuity digital PCR system and QIAGEN Digital Insights bioinformatics business both delivered high-single-digit ...